Pzena Investment Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $49.9M | Sell |
203,965
-41,986
| -17% | -$9.78M | 0.16% | 81 |
|
|
2025
Q4 | $50.9M | Sell |
245,951
-2,300
| -0.9% | -$455K | 0.15% | 76 |
|
|
2025
Q3 | $46M | Buy |
248,251
+1,938
| +0.8% | +$332K | 0.15% | 91 |
|
|
2025
Q2 | $37.6M | Buy |
246,313
+10,527
| +4% | +$1.62M | 0.12% | 98 |
|
|
2025
Q1 | $39.1M | Buy |
235,786
+6,806
| +3% | +$1.06M | 0.14% | 87 |
|
|
2024
Q4 | $33.1M | Sell |
228,980
-362
| -0.2% | -$56.1K | 0.11% | 100 |
|
|
2024
Q3 | $37.2M | Sell |
229,342
-802
| -0.3% | -$128K | 0.12% | 96 |
|
|
2024
Q2 | $33.6M | Sell |
230,144
-109
| -0% | -$16.2K | 0.12% | 99 |
|
|
2024
Q1 | $36.4M | Sell |
230,253
-407,409
| -64% | -$64.8M | 0.13% | 98 |
|
|
2023
Q4 | $99.9M | Buy |
637,662
+3,645
| +0.6% | +$559K | 0.38% | 51 |
|
|
2023
Q3 | $98.7M | Sell |
634,017
-323
| -0.1% | -$53.3K | 0.42% | 53 |
|
|
2023
Q2 | $105M | Buy |
634,340
+46
| +0% | +$7.42K | 0.45% | 51 |
|
|
2023
Q1 | $98.3M | Buy |
634,294
+290
| +0% | +$46.8K | 0.42% | 52 |
|
|
2022
Q4 | $112M | Sell |
634,004
-1,340
| -0.2% | -$231K | 0.5% | 47 |
|
|
2022
Q3 | $104M | Sell |
635,344
-1,999
| -0.3% | -$338K | 0.52% | 47 |
|
|
2022
Q2 | $113M | Sell |
637,343
-79,352
| -11% | -$14.1M | 0.51% | 46 |
|
|
2022
Q1 | $127M | Sell |
716,695
-164,709
| -19% | -$28M | 0.48% | 51 |
|
|
2021
Q4 | $151M | Sell |
881,404
-4,513
| -0.5% | -$739K | 0.57% | 45 |
|
|
2021
Q3 | $143M | Buy |
+885,917
| New | +$151M | 0.57% | 46 |
|
|
2017
Q3 | – | Sell |
-737,844
| Closed | -$97.6M | – | 157 |
|
|
2017
Q2 | $97.6M | Sell |
737,844
-176,595
| -19% | -$22.5M | 0.53% | 52 |
|
|
2017
Q1 | $114M | Sell |
914,439
-84,525
| -8% | -$10.1M | 0.64% | 49 |
|
|
2016
Q4 | $115M | Sell |
998,964
-3,350
| -0.3% | -$387K | 0.66% | 49 |
|
|
2016
Q3 | $118M | Sell |
1,002,314
-100,718
| -9% | -$12.2M | 0.72% | 43 |
|
|
2016
Q2 | $134M | Sell |
1,103,032
-82,297
| -7% | -$9.35M | 0.84% | 42 |
|
|
2016
Q1 | $128M | Buy |
1,185,329
+10,805
| +0.9% | +$1.12M | 0.79% | 41 |
|
|
2015
Q4 | $121M | Buy |
1,174,524
+355
| +0% | +$35.7K | 0.75% | 40 |
|
|
2015
Q3 | $110M | Hold |
1,174,169
| – | – | 0.7% | 41 |
|
|
2015
Q2 | $114M | Buy |
1,174,169
+153
| +0% | +$15.3K | 0.65% | 45 |
|
|
2015
Q1 | $118M | Sell |
1,174,016
-9,950
| -0.8% | -$1.01M | 0.66% | 44 |
|
|
2014
Q4 | $124M | Sell |
1,183,966
-450
| -0% | -$47.4K | 0.66% | 43 |
|
|
2014
Q3 | $126M | Buy |
1,184,416
+28,750
| +2% | +$2.98M | 0.69% | 42 |
|
|
2014
Q2 | $121M | Buy |
1,155,666
+287,527
| +33% | +$29.1M | 0.67% | 42 |
|
|
2014
Q1 | $85.3M | Buy |
868,139
+1,681
| +0.2% | +$156K | 0.49% | 49 |
|
|
2013
Q4 | $79.4M | Buy |
866,458
+18,700
| +2% | +$1.72M | 0.46% | 50 |
|
|
2013
Q3 | $73.5M | Buy |
847,758
+837,357
| +8,051% | +$75.1M | 0.47% | 49 |
|
|
2013
Q2 | $893K | Buy |
+10,401
| New | +$883K | 0.01% | 118 |
|
Other funds holding JNJ
VCM
VPM
Pzena Investment Management's JNJ Position: Q1 2026 in Review
Pzena Investment Management reduced its Johnson & Johnson (JNJ) stake by 17% in Q1 2026, selling an estimated $9.78M and leaving 203,965 shares worth $49.9M. The position accounts for 0.16% of the portfolio, ranked #81.
Pzena Investment Management first reported a position in JNJ in Q2 2013 and has held it in 36 quarters since. The position peaked at $151M in Q4 2021. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Pzena Investment Management held 203,965 shares of Johnson & Johnson worth $49.9M as of Q1 2026.
- Pzena Investment Management sold 41,986 Johnson & Johnson shares in Q1 2026, an estimated $9.78M.
- Johnson & Johnson made up 0.16% of Pzena Investment Management's portfolio in Q1 2026, its #81 holding.
- Pzena Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 36 quarters since.
- Pzena Investment Management's Johnson & Johnson position peaked at $151M in Q4 2021.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Pzena Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.